Aldeyra Therapeutics, Inc. (ALDX)
0.7664
-0.02
(-3.04%)
USD |
NASDAQ |
Oct 15, 13:57
Aldeyra Therapeutics EPS Diluted (Quarterly) : -0.0904 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0904 |
| March 31, 2026 | -0.0572 |
| December 31, 2025 | -0.1074 |
| September 30, 2025 | -0.1279 |
| June 30, 2025 | -0.1627 |
| March 31, 2025 | -0.1658 |
| December 31, 2024 | -0.2654 |
| September 30, 2024 | -0.2539 |
| June 30, 2024 | -0.2836 |
| March 31, 2024 | -0.136 |
| December 31, 2023 | -0.0803 |
| September 30, 2023 | -0.1388 |
| June 30, 2023 | -0.1529 |
| March 31, 2023 | -0.2656 |
| December 31, 2022 | -0.2203 |
| September 30, 2022 | -0.249 |
| June 30, 2022 | -0.305 |
| March 31, 2022 | -0.288 |
| December 31, 2021 | -0.2712 |
| September 30, 2021 | -0.2722 |
| June 30, 2021 | -0.2752 |
| March 31, 2021 | -0.2474 |
| December 31, 2020 | -0.292 |
| September 30, 2020 | -0.2348 |
| June 30, 2020 | -0.2497 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3378 |
| December 31, 2019 | -0.4735 |
| September 30, 2019 | -0.6903 |
| June 30, 2019 | -0.4939 |
| March 31, 2019 | -0.5775 |
| December 31, 2018 | -0.4052 |
| September 30, 2018 | -0.5156 |
| June 30, 2018 | -0.46 |
| March 31, 2018 | -0.4336 |
| December 31, 2017 | -0.36 |
| September 30, 2017 | -0.32 |
| June 30, 2017 | -0.35 |
| March 31, 2017 | -0.37 |
| December 31, 2016 | -0.37 |
| September 30, 2016 | -0.38 |
| June 30, 2016 | -0.41 |
| March 31, 2016 | -0.51 |
| December 31, 2015 | -0.4485 |
| September 30, 2015 | -0.35 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.32 |
| December 31, 2014 | -0.4393 |
| September 30, 2014 | -0.36 |
| June 30, 2014 | -1.56 |
| March 31, 2014 | -0.1774 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.450M |
| Total Expenses (Quarterly) | 5.450M |
| Enterprise Value | 2.731M |
| Earnings Yield | -49.96% |
| Normalized Earnings Yield | -49.96 |